IMPLANET announced the regulatory approval by Cofepris of its products based on the JAZZ Spine product range and the signing of a distribution contract with Novovascular Technologies for the marketing of these products in the Mexican market. Novovascular Technologies, a company that specializes in offering innovative products to health professionals, will have the commercial rights to the JAZZ platform in Mexico. This distribution agreement will allow Implanet to enter the Mexican spine market, the largest Central American market, estimated to be worth 60 million dollars2. The Mexican market was considered as a priority by Implanet in its internationalization plan, particularly due to the interest of the sub-laminar fixation technique resulting from the “Luqué” clinical experience in the treatment of spinal deformities. Implanet distributes its products either directly or via strong partnerships with high-quality distributors in more than 15 countries around the world. This new partnership further strengthens its sales potential overseas, complementing its already well-established activity in Brazil.